Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4KHR

HCV NS5B GT1A C316Y with GSK5852

Summary for 4KHR
Entry DOI10.2210/pdb4khr/pdb
Related4KAI 4KB7 4KBI 4KE5 4KHM
DescriptorNS5B RNA-dependent RNA polymerase, SULFATE ION, [4-({[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl](methylsulfonyl)amino}methyl)-2-fluorophenyl]boronic acid, ... (4 entities in total)
Functional Keywordshcv polymerase, hcv ns5b, site iv inhibitor, boron, p66, p70, rna dependent rna polymerase, rna directed rna polymerase, polymerase, rns dependent rna polymerase, replication-replication inhibitor complex, replication/replication inhibitor
Biological sourceHepatitis C virus subtype 1a (HCV)
Cellular locationVirion : B1PPP0
Total number of polymer chains2
Total formula weight129705.76
Authors
Williams, S.P.,Kahler, K.M.,Shotwell, J.B. (deposition date: 2013-05-01, release date: 2013-05-29, Last modification date: 2024-03-13)
Primary citationMaynard, A.,Crosby, R.M.,Ellis, B.,Hamatake, R.,Hong, Z.,Johns, B.A.,Kahler, K.M.,Koble, C.,Leivers, A.,Leivers, M.R.,Mathis, A.,Peat, A.J.,Pouliot, J.J.,Roberts, C.D.,Samano, V.,Schmidt, R.M.,Smith, G.K.,Spaltenstein, A.,Stewart, E.L.,Thommes, P.,Turner, E.M.,Voitenleitner, C.,Walker, J.T.,Waitt, G.,Weatherhead, J.,Weaver, K.,Williams, S.,Wright, L.,Xiong, Z.Z.,Haigh, D.,Shotwell, J.B.
Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.
J.Med.Chem., 57:1902-1913, 2014
Cited by
PubMed Abstract: A boronic acid moiety was found to be a critical pharmacophore for enhanced in vitro potency against wild-type hepatitis C replicons and known clinical polymorphic and resistant HCV mutant replicons. The synthesis, optimization, and structure-activity relationships associated with inhibition of HCV replication in a subgenomic replication system for a series of non-nucleoside boron-containing HCV RNA-dependent RNA polymerase (NS5B) inhibitors are described. A summary of the discovery of 3 (GSK5852), a molecule which entered clinical trials in subjects infected with HCV in 2011, is included.
PubMed: 23672667
DOI: 10.1021/jm400317w
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.45 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon